etiolog
agent
febril
respiratori
ill
commonli
refer
flu
lysosom
proteas
cathepsin
b
ctsb
shown
involv
lifecycl
variou
virus
examin
role
ctsb
iav
lifecycl
methodsctsbdefici
ctsb
macrophag
human
lung
epitheli
cell
line
cell
treat
infect
apuerto
strain
iav
viral
entri
propag
measur
quantit
realtim
rtpcr
product
local
hemagglutinin
ha
protein
infect
host
cell
analys
western
blot
flow
cytometri
confoc
microscopi
product
progeni
virus
measur
hemagglutin
assay
resultsctsb
macrophag
cell
defect
incorpor
virion
permit
viral
rna
synthesi
howev
cell
produc
significantli
lower
amount
ha
protein
progeni
virion
wildtyp
untreat
cell
conclusionthes
data
indic
ctsb
involv
express
ha
protein
subsequ
optim
product
progeni
virion
target
ctsb
novel
therapeut
strategi
treat
iav
infect
influenza
viru
envelop
viru
segment
negativesens
singlestrand
rna
genom
among
three
speci
influenza
virus
b
c
human
infect
commonli
caus
type
virus
iav
result
mild
febril
ill
death
genom
iav
encod
eleven
protein
eight
packag
progeni
virion
hemagglutinin
ha
neuraminidas
na
express
surfac
virion
envelop
glycoprotein
na
facilit
progeni
virion
releas
ha
respons
viru
entri
function
bind
spike
glycoprotein
ha
sialic
acid
moieti
host
plasma
membran
trigger
uptak
virion
endosom
endosom
traffick
toward
nucleu
acidifi
matur
ph
ha
undergo
irrevers
conform
chang
mediat
fusion
viral
envelop
endosom
membran
thu
releas
ribonucleoprotein
core
host
cytoplasm
cytoplasm
core
dissoci
newli
freed
viral
genom
activ
import
nucleu
replic
progeni
genom
transcript
mrna
take
place
viral
mrna
export
nucleu
translat
transmembran
protein
ha
na
synthes
rough
endoplasm
reticulum
deliv
plasma
membran
via
exocyt
pathway
target
cholesterolrich
lipid
raft
microdomain
progeni
virion
assembl
releas
accumul
ha
membran
trigger
nuclear
export
progeni
genom
membran
mediat
host
cytoskeleton
recycl
endosom
although
poorli
understood
process
bud
releas
thought
begin
deform
host
membran
possibl
due
hainduc
membran
curvatur
interact
matrix
protein
progeni
genom
scission
separ
fulli
form
viral
envelop
recent
studi
also
show
iav
usurp
host
autophagi
process
extracellularli
releas
progeni
virus
direct
autophagosom
plasma
membran
proton
channel
matrix
protein
play
key
role
direct
autophagosom
plasma
membran
directli
interact
autophagi
protein
proton
pump
activ
howev
involv
autophagi
process
factor
iav
exocytosi
still
remain
examin
cathepsin
b
ctsb
lysosom
cystein
proteas
primarili
involv
degrad
lysosom
protein
addit
role
protein
turnov
ctsb
play
key
role
lifecycl
sever
virus
includ
ebola
viru
nipah
viru
moloney
murin
leukemia
viru
felin
coronaviru
ctsb
catalyt
activ
viral
membran
glycoprotein
lead
viral
releas
endosom
cytoplasm
fusion
viral
envelop
endosom
membran
unenvelop
reoviru
use
ctsb
proteolyt
disassembl
viral
capsid
host
endosom
adenoassoci
viru
type
use
ctsb
cleav
capsid
protein
therebi
prime
rapid
capsid
disassembl
nucleu
catalyt
activ
ctsb
also
involv
optim
replic
herp
simplex
viru
type
dna
also
show
ctsb
involv
traffick
tumor
necrosi
factor
vesicl
plasma
membran
effici
releas
hiv
virion
macrophag
defici
function
ctsb
retain
tumor
necrosi
factor
hiv
virion
recycl
endosom
intracellular
multivesicular
bodi
examin
role
ctsb
iav
infect
use
ctsbdefici
ctsb
bone
marrowderiv
immort
macrophag
bmdim
human
lung
adenocarcinoma
cell
found
ctsb
play
key
role
optim
product
progeni
iav
synthet
ctsb
inhibitor
propylcarbamoyl
lisoleucyllprolin
methyl
ester
purchas
peptid
institut
inc
osaka
japan
actinomycin
actd
lysotrack
red
purchas
sigma
oakvil
canada
life
technolog
invitrogen
molecular
probe
strain
iav
apuerto
grown
embryon
chicken
egg
use
infecti
allanto
fluid
primari
antibodi
use
includ
polyclon
actin
rockland
monoclon
antiha
hybridoma
secondari
antibodi
use
includ
goat
antirabbit
igg
irdy
licor
lincon
unit
state
goat
antimous
igg
irdy
licor
lincon
unit
state
fluoresceinconjug
goat
antimous
igg
f
ab
fragment
jackson
immunoresearch
west
grove
unit
state
human
lung
adenocarcinoma
cell
grown
dmem
supplement
heatinactiv
fetal
bovin
serum
fb
vwr
mississauga
canada
mm
mem
nonessenti
amino
acid
solut
uml
penicillin
g
streptomycin
mm
sodium
pyruv
sigma
oakvil
canada
primari
immort
bone
marrowderiv
macrophag
bmdim
wildtyp
ctsb
mice
prepar
describ
previous
cell
grown
rpmi
supplement
heatinactiv
fetal
bovin
serum
fb
sigma
oakvil
canada
mm
mem
nonessenti
amino
acid
solut
uml
penicillin
g
streptomycin
mm
sodium
pyruv
cell
grown
c
humidifi
atmospher
contain
co
one
million
cell
place
ml
conic
tube
infect
moi
h
ml
pb
rotat
c
condit
actd
receiv
drug
time
infect
one
hour
adsorpt
ml
complet
cultur
medium
ad
cell
drug
applic
incub
continu
hour
rotat
c
seventi
five
thousand
cell
seed
microtit
plate
treat
presenc
absenc
drug
six
hour
c
reproduc
condit
infect
treatment
mtt
ad
final
concentr
mgml
incub
continu
addit
hour
cultur
medium
aspir
dmso
ad
solubil
purpl
formazan
crystal
min
incub
absorb
read
nm
use
plate
reader
valu
blank
well
averag
subtract
sampl
untreat
condit
serv
posit
control
viabil
calcul
briefli
rna
extract
cell
use
trizol
invitrogen
burlington
canada
revers
transcrib
mmulv
new
england
biolab
whitbi
canada
follow
manufactur
protocol
use
two
viral
genespecif
primer
yield
templat
cdna
see
one
sampl
amplifi
sybr
green
pcr
master
mix
invitrogen
burlington
canada
quantifi
use
rotorgen
corbett
life
scienc
kirkland
canada
follow
cycl
condit
c
min
c
sec
c
sec
c
sec
cycl
target
amplicon
two
gene
pcramplifi
standard
curv
gener
make
seri
tenfold
dilut
known
concentr
amplicon
use
calcul
copi
number
result
equat
use
determin
copi
number
unknown
sampl
base
ct
valu
describ
previous
ha
primer
gener
sequenc
specif
strain
influenza
genbank
use
ha
fwdrt
primer
ha
rev
primer
primer
gener
sequenc
report
literatur
highli
conserv
among
viral
subtyp
matrix
rev
primer
sampl
lyse
ice
minut
cold
lysi
buffer
mm
trishcl
mm
nacl
mm
edta
triton
sd
proteas
inhibitor
cocktail
roch
mississauga
canada
run
sd
gel
voltag
hour
protein
separ
gel
semidri
transfer
onto
pvdf
pall
life
scienc
mississauga
canada
hour
membran
block
wv
skim
milk
trisbuff
salin
tb
mm
trishcl
mm
nacl
ph
contain
tween
ttb
one
hour
probe
primari
antibodi
dilut
ttb
overnight
room
temperatur
follow
day
blot
wash
ttb
incub
secondari
antibodi
dilut
ttb
one
hour
blot
imag
use
licor
odyssey
system
guelph
canada
densitometr
analysi
western
blot
perform
use
densitometri
featur
imagej
nih
bethesda
unit
state
lane
analyz
result
histogram
use
measur
band
densiti
measur
area
peak
background
subtract
densiti
target
immunoreact
normal
load
control
data
analysi
bmdim
treat
moi
without
h
cell
wash
icecold
pb
sequenti
incub
antiha
antibodi
alexa
secondari
antibodi
min
cell
fix
parformaldehyd
analyz
flow
cytometri
use
fac
cantoii
bd
bioscienc
data
analysi
perform
use
cellquest
softwar
bd
bioscienc
fifti
thousand
cell
suspend
pb
seed
onto
coverslip
allow
attach
hour
cell
infect
high
moi
directli
pipet
viru
onto
coverslip
inhibitor
indic
ad
time
one
hour
adsorbt
period
ml
warm
media
inhibitor
applic
ad
contain
coverslip
incub
allow
continu
addit
hour
point
lysotrack
red
ad
final
concentr
nm
cell
incub
min
six
hour
infect
period
complet
cell
wash
pb
fix
formaldehyd
min
condit
requir
permeabil
cell
treat
triton
min
two
wash
pb
cell
block
pb
bsa
tween
one
hour
incub
antiha
primari
antibodi
dilut
overnight
c
follow
day
slide
wash
pb
incub
secondari
antimous
fitc
dilut
two
hour
slide
wash
incub
hoechst
min
dilut
rins
mount
view
use
zeiss
lsm
confoc
fluoresc
microscop
imag
acquir
use
zen
zeiss
toronto
canada
coloc
assess
use
jacop
plugin
imagej
hemagglutin
assay
perform
describ
previous
briefli
x
bmdim
cell
presenc
absenc
infect
moi
total
volum
ml
pb
one
hour
adsorpt
pb
viru
aspir
cell
wash
twice
pb
two
ml
fresh
serumfre
dmem
trypsin
ad
cell
along
applic
incub
continu
addit
h
serum
omit
contain
nonspecif
inhibitor
iav
infect
sinc
bmdim
show
signific
sensit
prolong
incub
serumfre
media
ml
complet
rpmi
ad
h
time
media
remov
cell
wash
twice
pb
two
ml
fresh
serumfre
rpmi
trypsin
ad
remain
h
h
incub
twenti
four
hour
postinfect
supernat
collect
centrifug
pellet
debri
fifti
condit
ad
pb
triplic
serial
dilut
twofold
pbsonli
control
posit
control
use
stock
viru
run
replic
fifti
adult
chicken
erythrocyt
charl
river
laboratori
wilmington
unit
state
solut
pb
ad
well
gentli
mix
incub
min
room
temperatur
well
score
either
posit
neg
titr
report
reciproc
highest
dilut
yield
agglutin
statist
analysi
perform
use
graphpad
prism
graphpad
softwar
san
diego
unit
state
result
consid
statist
signific
p
either
ttest
oneway
anova
follow
tukey
post
hoc
test
state
figur
legend
data
present
mean
sem
error
bar
denot
biolog
variat
experi
coloc
assess
use
jacop
plugin
imagej
determin
pearson
coeffici
numer
defin
degre
overlap
red
green
channel
examin
involv
ctsb
propag
first
examin
product
progeni
iav
virion
wildtyp
ctsbdefici
ctsb
bone
marrowderiv
immort
macrophag
bmdim
hemagglutin
assay
h
postinfect
releas
progeni
virion
ctsb
cell
less
wildtyp
cell
fig
sinc
ctsb
cell
defect
releas
virion
examin
whether
ctsb
involv
present
ha
surfac
infect
cell
end
wildtyp
cell
wildtyp
cell
treat
min
ctsb
cell
infect
moi
hour
amount
ha
cell
surfac
analyz
use
fac
wildtyp
nontreat
cell
cell
label
ha
antibodi
fig
red
line
howev
number
halabel
cell
decreas
treat
green
line
ctsb
cell
orang
line
respect
result
suggest
ctsb
catalyt
activ
requir
proper
plasma
membran
present
ha
protein
examin
whether
ctsb
involv
entri
replic
wildtyp
ctsb
cell
infect
presenc
absenc
actinomycin
actd
actd
transcript
inhibitor
use
extens
influenza
research
block
viral
replic
prevent
nuclear
import
viral
genom
therefor
cell
treat
actd
contain
genet
materi
viral
protein
endocytos
origin
inoculum
afford
accur
mean
assess
viral
endocytosi
absenc
replic
product
extent
viral
entri
replic
determin
realtim
rtqpcr
two
viral
gene
hemagglutinin
ha
specif
strain
iav
matrix
gene
highli
conserv
among
iav
subtyp
rtqpcr
proven
use
tool
quantifi
influenza
particl
due
part
sensit
genet
natur
viru
packag
one
copi
viral
gene
per
virion
thu
calcul
copi
number
accur
reflect
absolut
number
virion
present
shown
fig
rna
copi
number
ha
left
panel
right
panel
similar
wildtyp
ctsb
cell
treat
actd
copi
number
ha
higher
cell
without
actd
treatment
indic
product
new
viral
rna
actd
influenc
viabil
cell
data
shown
sinc
ctsb
involv
either
viral
entri
rna
synthesi
examin
whether
ha
protein
express
defect
ctsb
cell
end
cell
lysat
iavinfect
wildtyp
ctsb
cell
presenc
absenc
actd
subject
western
blot
analysi
viral
ha
protein
densitometr
analysi
immunereact
band
perform
intens
normal
shown
fig
amount
ha
protein
detect
significantli
lower
ctsb
cell
wildtyp
cell
similar
result
also
obtain
primari
bone
marrowderiv
macrophag
prepar
wildtyp
mice
fig
examin
whether
involv
ctsb
product
specif
murin
macrophag
perform
similar
experi
use
human
lung
epitheli
cell
line
cell
cell
close
approxim
respiratori
epithelium
infect
vivo
commonli
use
influenza
research
consist
data
obtain
ctsb
bmdim
effect
viral
rna
copi
number
ha
cell
absenc
presenc
actd
fig
howev
western
blot
ha
protein
show
significantli
decreas
band
intens
cell
treat
compar
nontreat
cell
fig
sinc
ha
band
detect
cell
treat
actd
ha
protein
shown
western
blot
like
repres
newli
synthes
ha
protein
fig
treatment
effect
viabil
cell
data
shown
translat
ha
rna
ha
protein
traffick
host
plasma
membran
via
golgi
network
embed
cell
surfac
sinc
ctsb
shown
role
traffick
function
possibl
inhibit
may
disrupt
transport
ha
subsequ
target
cargo
destruct
lysosom
thu
examin
whether
ha
protein
prevent
transport
plasma
membran
redirect
lysosom
degrad
may
result
defect
infect
adjac
cell
overal
decreas
ha
protein
product
end
cell
infect
presenc
absenc
andor
actd
ha
protein
visual
confoc
immunofluoresc
microscopi
nontreat
cell
infect
moi
yield
even
stain
pattern
ha
green
plasma
membran
mani
cell
fig
left
panel
treatment
either
actd
abolish
stain
pattern
instead
aggreg
puncta
surfac
cell
visibl
limit
number
cell
right
panel
sinc
ha
detect
cell
treat
actd
western
blot
fig
aggreg
puncta
detect
actdtreat
cell
could
virus
inocul
elimin
signal
inocul
virus
quantifi
product
haposit
vesicl
cell
infect
moi
cell
permeabil
immunostain
shown
fig
nontreat
cell
show
distinct
punta
wherea
actdtreat
cell
show
aggreg
puncta
significantli
less
intracellular
stain
ha
rel
untreat
cell
actdtreat
cell
show
almost
intracellular
stain
fig
middl
right
panel
fig
furthermor
coloc
ha
late
endosomelysosom
quantifi
use
analysi
describ
found
appar
coloc
compart
condit
pearson
coeffici
untreat
actdtreat
cell
respect
sever
studi
identifi
ctsb
key
factor
involv
progress
variou
viral
lifecycl
case
role
ctsb
proteolyt
activ
viral
protein
facilit
escap
cytoplasm
follow
endocytosi
given
iav
use
endosom
enter
host
cell
transport
viral
genom
nucleu
examin
role
ctsb
earli
stage
viral
lifecycl
howev
signific
differ
wildtyp
ctsb
bmdim
nontreat
cell
detect
viral
entri
subsequ
replic
fig
data
indic
ctsb
play
appar
role
earli
lifecycl
expect
cell
treat
actd
lower
copi
number
ha
rna
untreat
bmdim
cell
howev
notabl
differ
titr
achiev
cell
term
entri
replic
presenc
actd
cell
show
fewer
copi
gene
x
compar
bmdim
x
moi
viral
inoculum
contain
approxim
particl
suggest
approxim
inoculum
infect
cell
bmdim
contain
viral
rna
copi
inocul
larg
amount
viral
rna
bmdim
could
due
phagocyt
natur
cell
propens
influenza
viru
gener
defect
particl
cultur
convers
absenc
actd
cell
produc
viral
rna
bmdim
x
versu
x
may
reflect
permiss
respect
cell
type
infect
consist
previou
observ
iav
replic
higher
titr
epitheli
cell
macrophag
eleven
protein
gener
iav
infect
ha
absolut
crucial
infect
virion
lack
ha
noninfecti
due
inabl
bind
host
cell
escap
endosom
follow
endocytosi
ha
protein
also
abundantli
express
infect
cell
easili
detect
western
blot
cytometri
analysi
therefor
ha
express
examin
marker
viral
protein
product
approxim
h
postinfect
background
host
protein
dramat
reduc
cellular
machineri
usurp
product
viral
protein
viral
protein
includ
ha
detect
h
post
infect
stabl
h
unlik
case
entri
replic
ctsb
bmdim
cell
contain
significantli
less
amount
ha
protein
wildtyp
nontreat
cell
respect
measur
h
postinfect
fig
also
ha
protein
detect
infect
cell
presenc
actd
fig
suggest
immunoreact
ha
band
detect
newli
synthes
viral
protein
collect
data
suggest
ctsb
requir
optim
product
ha
protein
examin
fate
ha
protein
ctsbdefici
cell
cell
infect
presenc
absenc
actd
visual
use
confoc
immunofluoresc
microscopi
found
cell
notic
reduct
number
size
haposit
puncta
coloc
late
endosomeslysosom
fig
suggest
ha
protein
like
target
lysosom
degrad
cell
defect
ctsb
activ
lysosom
degrad
pathway
inhibitor
chloroquin
also
induc
accumul
ha
protein
cell
treat
ctsb
cell
data
shown
howev
inhibit
endosom
matur
could
inhibit
viral
releas
endosom
host
cytoplasm
obscur
data
interpret
ubiquitinproteasom
degrad
pathway
altern
process
protein
degrad
howev
proteosom
inhibitor
also
caus
increas
ha
protein
express
ctsb
bmdim
cell
data
shown
therefor
studi
requir
determin
ctsb
enhanc
product
ha
protein
level
protein
degrad
synthesi
nonetheless
clear
ctsb
requir
optim
product
ha
protein
genet
defect
chemic
inhibit
ctsb
express
result
impair
surfac
present
ha
protein
progeni
virion
product
fig
measur
progeni
viru
product
use
hemagglutin
assay
measur
viral
titr
basi
ha
protein
surfac
particl
progeni
virion
acquir
ha
envelop
glycoprotein
passiv
bud
infect
host
cell
bear
protein
membran
absenc
ha
host
membran
could
sever
deleteri
consequ
consid
ha
critic
endocytosi
endosom
escap
export
packag
progeni
genom
thu
progeni
lack
ha
releas
infect
cell
like
possess
defect
relat
one
function
resist
circul
iav
strain
older
antivir
amantadin
well
newer
antivir
oseltamivir
increas
alarm
rate
past
decad
given
rate
antivir
therapi
becom
obsolet
due
viral
mutat
effect
strategi
would
target
host
rather
viral
compon
requir
effect
replic
iav
previous
iav
shown
elev
ctsb
activ
express
facilit
antigen
process
dendrit
cell
murin
cell
also
show
defici
ctsb
lead
defect
iav
virion
product
suggest
target
ctsb
could
novel
therapeut
strategi
iav
infect
wildtyp
ctsb
bmdim
infect
influenza
h
moi
presenc
absenc
actinomycin
actd
cell
harvest
total
rna
extract
use
rtqpcr
analysi
hemagglutinin
ha
matrix
protein
panspecif
data
express
mean
sem
least
three
independ
experi
ns
signific
bc
similarli
bmdim
b
primari
bone
marrowderiv
macrophag
c
infect
harvest
lyse
subject
western
blot
influenza
ha
protein
b
repres
western
blot
ha
protein
load
control
present
top
panel
densitometr
analysi
bad
perform
result
express
mean
sem
n
bottom
panel
c
repres
western
blot
ha
protein
two
separ
experi
present
cell
pretreat
differ
concentr
min
infect
influenza
viru
strain
h
moi
presenc
absenc
actinomycin
actd
cell
harvest
total
rna
extract
use
rtqpcr
analysi
hemagglutinin
upper
panel
matrix
lower
panel
rna
data
express
mean
sem
least
three
independ
experi
column
accompani
letter
significantli
differ
tukey
post
hoc
test
p
b
similarli
cell
treat
dose
indic
infect
harvest
lyse
subject
western
blot
influenza
ha
protein
result
blot
use
densitometr
analysi
repres
western
blot
ha
protein
load
control
present
upper
panel
data
express
mean
sem
least
three
independ
experi
lower
panel
c
western
blot
ha
protein
cell
treat
actd
present
